Rubedo Life Sciences has completed Phase 1 clinical trials across four skin conditions. Marco Quarta is a leading researcher in cellular senescence and explains what he's learned from the complexity uncovered in clinical senescent cell research in…
Anonymous readers can preview up to 1024 characters here. Log in to unlock the full article once ingest succeeds.
